Prevalence of multiple malignancies in the Netherlands in 2007

International Journal of Cancer

Volumn 128, Issue 7, 2011, Pages 1659-1667

  Liu, Lifang ^a   De Vries, Esther ^a   Louwman, Marieke ^b,c   Aben, Katja ^c,d   Janssen Heijnen, Maryska ^b,c   Brink, Mirian ^c   Coebergh, Jan Willem ^a,b   Soerjomataram, Isabelle ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b The Netherlands   (Netherlands)

^c Netherlands Cancer Registry   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

neoplasms; prevalence; second primary; survivors

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; CANCER SURVIVOR; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENITAL TRACT CANCER; HODGKIN DISEASE; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CANCER; MULTIPLE CANCER; NETHERLANDS; NONHODGKIN LYMPHOMA; PHARYNX CANCER; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SKIN CANCER; SOFT TISSUE CANCER; SQUAMOUS CELL CARCINOMA; URINARY TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; NETHERLANDS; PREVALENCE; REGISTRIES;

EID: 79551479656     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25480     Document Type: Article

References (50)

1. Dutch Comprehensive Cancer Centres. Available at:. Accessed on July 14, 2009.
2. Kanker in Netherland. Trends, prognoses, en implicatie voor zorgvraag. 2004. 2004.
3. Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ,. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev 2007; 16: 566-71.
4. Ries LAG MD, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, et al., eds. SEER cancer statistics review, 1975-2005. Bethesda, MD: National Cancer Institute, 2007.
5. Brennan P, Scelo G, Hemminki K, Mellemkjaer L, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV, Tonita JM, Seow A, et al. Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. Br J Cancer 2005; 93: 159-66.
6. Hashibe M, Ritz B, Le AD, Li G, Sankaranarayanan R, Zhang ZF,. Radiotherapy for oral cancer as a risk factor for second primary cancers. Cancer Lett 2005; 220: 185-95.
7. Mellemkjaer L, Friis S, Olsen JH, Scelo G, Hemminki K, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV, Tonita JM, et al. Risk of second cancer among women with breast cancer. Int J Cancer 2006; 118: 2285-92.
8. Scelo G, Boffetta P, Hemminki K, Pukkala E, Olsen JH, Andersen A, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, et al. Associations between small intestine cancer and other primary cancers: an international population-based study. Int J Cancer 2006; 118: 189-96.
9. Richiardi L, Scelo G, Boffetta P, Hemminki K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, et al. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries. Int J Cancer 2007; 120: 623-31. (Pubitemid 44969034)
10. Riska A, Pukkala E, Scelo G, Mellemkjaer L, Hemminki K, Weiderpass E, McBride ML, Pompe-Kirn V, Tracey E, Brewster DH, Kliewer EV, Tonita JM, et al. Second primary malignancies in females with primary fallopian tube cancer. Int J Cancer 2007; 120: 2047-51.
11. Scelo G, Boffetta P, Autier P, Hemminki K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, et al. Associations between ocular melanoma and other primary cancers: an international population-based study. Int J Cancer 2007; 120: 152-9.
12. Chuang SC, Scelo G, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, Hemminki K, Weiderpass E, Pukkala E, Tracey E, Friis S, Pompe-Kirn V, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer 2008; 123: 2390-6.
13. de Vries E, Soerjomataram I, Houterman S, Louwman MW, Coebergh JW,. Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation? Am J Epidemiol 2007; 165: 966-72.
14. Soerjomataram I, Louwman WJ, de Vries E, Lemmens VE, Klokman WJ, Coebergh JW,. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001. Breast Cancer Res Treat 2005; 93: 91-5.
15. Soerjomataram I, Louwman WJ, Lemmens VE, Coebergh JW, de Vries E,. Are patients with skin cancer at lower risk of developing colorectal or breast cancer?. Am J Epidemiol 2008; 167: 1421-9.
16. Soerjomataram I, Louwman WJ, Lemmens VE, de Vries E, Klokman WJ, Coebergh JW,. Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972-2001. Eur J Cancer 2005; 41: 2331-7. (Pubitemid 41415610)
17. Soerjomataram I, Louwman WJ, van der Sangen MJ, Roumen RM, Coebergh JW,. Increased risk of second malignancies after in situ breast carcinoma in a population-based registry. Br J Cancer 2006; 95: 393-7.
18. Soerjomataram I, Vries Ed,. Correspondence: Author reply: a further caveat in interpreting cancer survival. Nat Rev Clin Oncol 2010; 7.
19. Rosso S, De Angelis R, Ciccolallo L, Carrani E, Soerjomataram I, Grande E, Zigon G, Brenner H,. Multiple tumours in survival estimates. Eur J Cancer 2009; 2: 2.
20. Thornton AA, Madlensky L, Flatt SW, Kaplan RM, Pierce JP,. The impact of a second breast cancer diagnosis on health related quality of life. Breast Cancer Res Treat 2005; 92: 25-33.
21. Giles G,. How important are estimates of cancer prevalence?. Ann Oncol 2002; 13: 815-6.
22. Zanetti R, Micheli A, Rosso S, Sant M,. The prevalence of cancer: a review of the available data. Tumori 1999; 85: 408-13.
23. Dutch Comprehensive Cancer Centres, Available at:, Accessed on July 14, 2009
24. International Association of Cancer Registries (IACR). International rules for multiple primary cancers. Asian Pac J Cancer Prev 2005; 6: 104-6.
25. Curtis RE FD, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF, Jr,. New malignancies among cancer survivors: SEER cancer registries, 1973-2000. Bethesda, MD: National Cancer Institute, 2006.
26. de Vries E, Louwman M, Bastiaens M, de Gruijl F, Coebergh JW,. Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973. J Invest Dermatol 2004; 123: 634-8.
27. Available at:, Accessed on July 14th 2009.
28. Available at:, Accessed on July 14th 2009.
29. Janssen-Heijnen ML, Coebergh JW,. The changing epidemiology of lung cancer in Europe. Lung Cancer 2003; 41: 245-58.
30. Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW,. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 2005; 55: 231-40.
31. Janssen-Heijnen ML, Maas HA, Houterman S, Lemmens VE, Rutten HJ, Coebergh JW,. Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer 2007; 43: 2179-93.
32. Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, van Leeuwen FE, Holowaty EJ, Andersson M, Wiklund T, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002; 20: 3484-94.
33. Travis LB, Curtis RE, Storm H, Hall P, Holowaty E, Van Leeuwen FE, Kohler BA, Pukkala E, Lynch CF, Andersson M, Bergfeldt K, Clarke EA, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 1997; 89: 1429-39. (Pubitemid 27419206)
34. van Leeuwen FE, Stiggelbout AM, van den Belt-Dusebout AW, Noyon R, Eliel MR, van Kerkhoff EH, Delemarre JF, Somers R,. Second cancer risk following testicular cancer: a follow-up study of 1,909 patients. J Clin Oncol 1993; 11: 415-24.
35. Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, Joensuu T, Lynch CF, van Leeuwen FE, Holowaty E, Storm H, Glimelius I, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002; 94: 182-92.
36. Chuang SC, Hashibe M, Scelo G, Brewster DH, Pukkala E, Friis S, Tracey E, Weiderpass E, Hemminki K, Tamaro S, Chia KS, Pompe-Kirn V, et al. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev 2008; 17: 1543-9.
37. Hemminki K, Scelo G, Boffetta P, Mellemkjaer L, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride M, Kliewer EV, Chia KS, Pompe-Kirn V, et al. Second primary malignancies in patients with male breast cancer. Br J Cancer 2005; 92: 1288-92.
38. Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Pukkala E, Lynch CF, Pee D, Smith SA, et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 2005; 97: 1428-37.
39. Hill DA, Gilbert E, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, Van't Veer M, Storm H, et al. Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. Blood 2005; 106: 3358-65.
40. Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, Van't Veer MB, Glimelius I, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003; 290: 465-75.
41. Brinton LA LJJ, Devesa SS,. Epidemiology of breast cancer In:, Donegan WL SJe, ed. Cancer of the breast, 5th edn. Philadelphia: Saunders, 2002. 111-32.
42. Brinton LA LJJ, Sherman ME,. Epidemiology of gynecologic cancers. In:, Hoskins WJ PCYRe, ed. Principles and practice of gynecologic oncology, 4th edn. Philadelphia: Lippincott Williams & Wiklkins, 2005. 3-32.
43. Nelson HD, Huffman LH, Fu R, Harris EL,. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2005; 143: 362-79.
44. Hemminki K, Jiang Y, Steineck G,. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function? Eur J Cancer 2003; 39: 223-9.
45. Travis LB,. Therapy-associated solid tumors. Acta Oncol 2002; 41: 323-33.
46. Thong MS, Mols F, Coebergh JW, Roukema JA, van de Poll-Franse LV,. The impact of disease progression on perceived health status and quality of life of long-term cancer survivors. J Cancer Surviv 2009; 3: 164-73.
47. Capocaccia R, De Angelis R,. Estimating the completeness of prevalence based on cancer registry data. Stat Med 1997; 16: 425-40.
48. NCI. 2006b. SEER Program Coding and Staging Available at: Manual:, Assessed on July 14th, 2009.
49. Percy-Laurry AL, Johnson CH, Reichman ME, Adamo M, Lewis DR, Peace S,. Revising the multiple primary and histology coding rules. J Regist Manag 2007; 34: 81-6.
50. Janssen-Heijnen ML, Houterman S, Lemmens VE, Brenner H, Steyerberg EW, Coebergh JW,. Prognosis for long-term survivors of cancer. Ann Oncol 2007; 18: 1408-13.